Skip to main content

Table 2 Nabiximols/placebo titration regimen

From: A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial

Day

Number of Sprays

Morning

Between waking-up and 12pm

Afternoon

Between 4pm and bedtime

Total number of sprays per day

1

0

1

1

2

0

1

1

3

0

2

2

4

0

2

2

5

1

2

3

6

1

3

4

7

1

4

5

8

2

4

6

9

2

5

7

10

3

5

8

11

3

6

9

12

4

6

10

13

4

7

11

14

5

7

12

  1. Taken from the nabiximols Summary of Product Characteristics [29]